• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用 CT 成像评估宫颈癌放疗后晚期胃肠道副作用:风险回归分析。

Utilizing CT imaging for evaluating late gastrointestinal tract side effects of radiotherapy in uterine cervical cancer: a risk regression analysis.

机构信息

Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Division of Diagnostic Radiology, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

出版信息

BMC Med Imaging. 2024 Sep 9;24(1):235. doi: 10.1186/s12880-024-01420-3.

DOI:10.1186/s12880-024-01420-3
PMID:39251973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11385497/
Abstract

BACKGROUND

Radiotherapy (RT) is effective for cervical cancer but causes late side effects (SE) to nearby organs. These late SE occur more than 3 months after RT and are rated by clinical findings to determine their severity. While imaging studies describe late gastrointestinal (GI) SE, none demonstrate the correlation between the findings and the toxicity grading. In this study, we demonstrated the late GI toxicity prevalence, CT findings, and their correlation.

METHODS

We retrospectively studied uterine cervical cancer patients treated with RT between 2015 and 2018. Patient characteristics and treatment(s) were obtained from the hospital's databases. Late RTOG/EORTC GI SE and CT images were obtained during the follow-up. Post-RT GI changes were reviewed from CT images using pre-defined criteria. Risk ratios (RR) were calculated for CT findings, and multivariable log binomial regression determined adjusted RRs.

RESULTS

This study included 153 patients, with a median age of 57 years (IQR 49-65). The prevalence of ≥ grade 2 RTOG/EORTC late GI SE was 33 (27.5%). CT findings showed 91 patients (59.48%) with enhanced bowel wall (BW) thickening, 3 (1.96%) with bowel obstruction, 7 (4.58%) with bowel perforation, 6 (3.92%) with fistula, 0 (0%) with bowel ischemia, and 0 (0%) with GI bleeding. Adjusted RRs showed that enhanced BW thickening (RR 9.77, 95% CI 2.64-36.07, p = 0.001), bowel obstruction (RR 5.05, 95% CI 2.30-11.09, p < 0.001), and bowel perforation (RR 3.82, 95% CI 1.96-7.44, p < 0.001) associated with higher late GI toxicity grades.

CONCLUSIONS

Our study shows CT findings correlate with grade 2-4 late GI toxicity. Future research should validate and refine these findings with different imaging and toxicity grading systems to assess their potential predictive value.

摘要

背景

放射治疗(RT)对宫颈癌有效,但会导致附近器官的晚期副作用(SE)。这些晚期 SE 在 RT 后 3 个月以上发生,并通过临床发现进行评估以确定其严重程度。虽然影像学研究描述了晚期胃肠道(GI)SE,但没有一项研究显示这些发现与毒性分级之间的相关性。在这项研究中,我们展示了晚期 GI 毒性的发生率、CT 表现及其相关性。

方法

我们回顾性研究了 2015 年至 2018 年间接受 RT 治疗的子宫颈癌患者。从医院的数据库中获取患者特征和治疗信息。在随访期间获得晚期 RTOG/EORTC GI SE 和 CT 图像。使用预定义标准从 CT 图像中回顾性评估 RT 后 GI 变化。计算 CT 表现的风险比(RR),并使用多变量对数二项式回归确定调整后的 RR。

结果

本研究共纳入 153 例患者,中位年龄为 57 岁(IQR 49-65)。≥2 级 RTOG/EORTC 晚期 GI SE 的发生率为 33(27.5%)。CT 表现显示 91 例(59.48%)患者的肠壁增厚(BW)强化,3 例(1.96%)患者出现肠梗阻,7 例(4.58%)患者出现肠穿孔,6 例(3.92%)患者出现瘘管,0 例(0%)患者出现肠缺血,0 例(0%)患者出现 GI 出血。调整后的 RR 显示,肠壁增厚(RR 9.77,95%CI 2.64-36.07,p=0.001)、肠梗阻(RR 5.05,95%CI 2.30-11.09,p<0.001)和肠穿孔(RR 3.82,95%CI 1.96-7.44,p<0.001)与晚期 GI 毒性分级较高相关。

结论

我们的研究表明 CT 表现与 2-4 级晚期 GI 毒性相关。未来的研究应使用不同的影像学和毒性分级系统来验证和完善这些发现,以评估其潜在的预测价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5020/11385497/c50ab5d4421e/12880_2024_1420_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5020/11385497/c50ab5d4421e/12880_2024_1420_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5020/11385497/c50ab5d4421e/12880_2024_1420_Fig1_HTML.jpg

相似文献

1
Utilizing CT imaging for evaluating late gastrointestinal tract side effects of radiotherapy in uterine cervical cancer: a risk regression analysis.利用 CT 成像评估宫颈癌放疗后晚期胃肠道副作用:风险回归分析。
BMC Med Imaging. 2024 Sep 9;24(1):235. doi: 10.1186/s12880-024-01420-3.
2
Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers.降低原发性盆腔癌盆腔放疗急慢性胃肠道不良反应的干预措施。
Cochrane Database Syst Rev. 2018 Jan 23;1(1):CD012529. doi: 10.1002/14651858.CD012529.pub2.
3
The Clinical Course of the Late Toxicity of Definitive Radiotherapy in Cervical Cancer.宫颈癌根治性放疗晚期毒性的临床病程。
Medicina (Kaunas). 2024 Aug 21;60(8):1364. doi: 10.3390/medicina60081364.
4
Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin.宫颈癌调强放疗同期顺铂化疗后急性胃肠道毒性正常组织并发症概率分析
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):e81-6. doi: 10.1016/j.ijrobp.2011.12.012.
5
Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.接受盆腔外野调强放疗治疗宫颈癌和子宫内膜癌后的十二指肠和其他胃肠道毒性。
Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1262-8. doi: 10.1016/j.ijrobp.2012.10.004. Epub 2012 Nov 20.
6
Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose.调强放疗可降低盆腔中等剂量放疗时的胃肠道毒性。
PLoS One. 2017 Aug 28;12(8):e0183339. doi: 10.1371/journal.pone.0183339. eCollection 2017.
7
Multivariate normal tissue complication probability modeling of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.外照射放疗局限性前列腺癌后胃肠道毒性的多变量正态组织并发症概率模型。
Radiat Oncol. 2013 Sep 23;8:221. doi: 10.1186/1748-717X-8-221.
8
Utility of upper endoscopy and colonoscopy in evaluating gastrointestinal luminal wall thickening found on computed tomography.上消化道内镜检查和结肠镜检查在评估计算机断层扫描发现的胃肠道腔壁增厚中的应用
W V Med J. 2010 Nov-Dec;106(7):16-9.
9
Clinical features, outcome and risk factors in cervical cancer patients after surgery for chronic radiation enteropathy.宫颈癌患者慢性放射性肠病手术后的临床特征、结局及危险因素
Radiat Oncol. 2015 Jun 6;10:128. doi: 10.1186/s13014-015-0433-5.
10
Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.前列腺癌放疗后的急性和晚期并发症:一项比较68 Gy与78 Gy的多中心随机试验结果
Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1019-34. doi: 10.1016/j.ijrobp.2004.07.715.

本文引用的文献

1
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.ESGO/ESTRO/ESP 宫颈癌管理指南-2023 年更新版。
Int J Gynecol Cancer. 2023 May 1;33(5):649-666. doi: 10.1136/ijgc-2023-004429.
2
Update on the management of the gastrointestinal effects of radiation.放射治疗胃肠道反应管理的最新进展
World J Gastrointest Oncol. 2021 May 15;13(5):400-408. doi: 10.4251/wjgo.v13.i5.400.
3
Bowel morbidity following radiochemotherapy and image-guided adaptive brachytherapy for cervical cancer: Physician- and patient reported outcome from the EMBRACE study.
宫颈癌放化疗及影像引导自适应近距离放疗后肠道并发症:EMBRACE 研究中医生和患者报告的结局。
Radiother Oncol. 2018 Jun;127(3):431-439. doi: 10.1016/j.radonc.2018.05.016. Epub 2018 Jun 4.
4
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.宫颈癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2017 Jul 1;28(suppl_4):iv72-iv83. doi: 10.1093/annonc/mdx220.
5
Pelvic radiation disease: Updates on treatment options.盆腔放射性疾病:治疗选择的最新进展
World J Clin Oncol. 2015 Dec 10;6(6):272-80. doi: 10.5306/wjco.v6.i6.272.
6
Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.抗癌治疗期间出现的有症状毒性:三项随机试验中患者报告和医生报告的一致性。
J Clin Oncol. 2015 Mar 10;33(8):910-5. doi: 10.1200/JCO.2014.57.9334. Epub 2015 Jan 26.
7
Pelvic radiation disease.盆腔放射性疾病
Colorectal Dis. 2015 Jan;17(1):2-6. doi: 10.1111/codi.12812.
8
Structured gastroenterological intervention and improved outcome for patients with chronic gastrointestinal symptoms following pelvic radiotherapy.盆腔放疗后慢性胃肠道症状患者的结构化胃肠病学干预和改善结局。
Support Care Cancer. 2013 Aug;21(8):2255-65. doi: 10.1007/s00520-013-1782-y. Epub 2013 Mar 21.
9
Imaging effects of radiation therapy in the abdomen and pelvis: evaluating "innocent bystander" tissues.腹部和骨盆放射治疗的影像学效应:评估“无辜旁观者”组织。
Radiographics. 2013 Mar-Apr;33(2):599-619. doi: 10.1148/rg.332125119.
10
ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs--threshold doses for tissue reactions in a radiation protection context.国际放射防护委员会第118号出版物:国际放射防护委员会关于正常组织和器官中辐射的组织反应及早期和晚期效应的声明——辐射防护背景下组织反应的阈值剂量
Ann ICRP. 2012 Feb;41(1-2):1-322. doi: 10.1016/j.icrp.2012.02.001.